SlideShare a Scribd company logo
1 of 12
RADIOLOGICAL DAMAGE IN RHEUMATOID ARTHRTITIS IS ASSOCIATED WITH IL-6 AND IL-10 GENOTYPES INDEPENDENT OF AUTOANTIBODY PRODUCTION I Marinou, J Healy, D Mewar, D J Moore, M C Dickson, M H Binks, D S Montgomery, K Walters and A G Wilson Section of Musculoskeletal Sciences, School of Medicine & Biomedical Sciences, The University of Sheffield
Genetic contribution to radiological damage ,[object Object],[object Object]
Genetic factors and RA severity ,[object Object],[object Object],[object Object],[object Object]
Hypothesis ,[object Object]
Methods ,[object Object],[object Object],[object Object],[object Object]
Associations of functional SNPs in IL-10 and IL-6 genes with radiographic severity of RA   *  Median modified Larsen scores  †Cuzic’s test for trend 31 259 (30.1%) GG 0.01 † 27 415 (48.3%) AG (n=860) 24 186 (21.6%) AA IL-10-1082 32 587 (63.3%) CC 0.006 22 309 (33.3%) AC (n=928) 28 32 (3.4%) AA IL-10-592 34 282 (30.3%) GG 0.005 † 27 482 (51.8%) CG (n=930) 25 166 (17.8%) CC IL-6-174 p LS *   Cases n (%) Genotype Gene D’=0.89 R 2 =0.24
Functional SNPs in IL-10 and IL-6 are not associated with autoantibody production   The presence of anti-CCP and RF was compared for each SNP with reference to the commonest genotype 78 159 57 191 GG 0.8 1.0 (0.7-1.4) 129 253 0.2 0.8 (0.5-1.1) 113 291 AG 0.6 1.1 (0.7-1.8) 52 120 0.6 1.1 (0.7-1.9) 36 138 AA IL-10-1082 169 375 138 432 CC 0.5 0.9 (0.7-1.2) 96 191 0.9 1.0 (.07-1.4) 72 222 AC 0.6 1.4 (0.6-3.7) 8 25 0.5 1.5 (06-4.5) 6 28 AA IL-10-592 77 184 64 207 GG 0.6 0.9 (0.6-1.3) 140 304 0.9 1.0 (0.7-1.4) 112 351 CG 0.1 0.7 (0.5-1.1) 56 98 0.7 0.9 (0.6-1.5) 40 120 CC IL-6-174 p OR (95%CI) RF-ve RF+ve p OR (95%CI) CCP-ve CCP+ve Genotype Gene RF status CCP status
Associations of SNPs with RA severity are influenced by RF and CCP status   Radiographic damage and genotypes stratified by CCP and RF status. Median LS is compared across genotypes according to CCP and RF status.  0.05 40 375 CC 0.002** 16 135 CC 0.002** 19 168 CC 11 103 AA/AC RF- 31 216 AA/AC RF+ 6 76 AA/AC CCP- 0.06 37 431 CC 29 250 AA/AC CCP+ IL-10 -592 p LS n Genotype Antibody status SNP
Radiographic damage and genotypes stratified by CCP and RF status. Median LS is compared across genotypes according to CCP and RF status.  13 76 GG 0.5 17 139 GC 13 56 CC RF- 44 184 GG 0.01** 34 304 GC 30 98 CC RF+ 10 63 GG 0.9 13 109 GC 13 39 CC CCP- 41 207 GG 0.004** 32 350 GC 29 120 CC CCP+ IL-6 -174 p LS n Genotype Antibody status SNP
In summary ,[object Object],[object Object],[object Object],[object Object],[object Object]
Study limitations ,[object Object],[object Object],[object Object]
Conclusion ,[object Object],[object Object]

More Related Content

What's hot

which RA patients fits to require anti TNF alpha
which RA patients fits to require anti TNF alphawhich RA patients fits to require anti TNF alpha
which RA patients fits to require anti TNF alphaTabib Sendi
 
Cardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial InfarctionCardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial InfarctionInsideScientific
 
Copy number variations in monozygotic twins discordant for schizophrenia
Copy number variations in monozygotic twins discordant for schizophreniaCopy number variations in monozygotic twins discordant for schizophrenia
Copy number variations in monozygotic twins discordant for schizophreniaccastel3
 
Cixutumumab imc a12 ottobre 2010
Cixutumumab imc a12 ottobre 2010Cixutumumab imc a12 ottobre 2010
Cixutumumab imc a12 ottobre 2010coolesanum
 
testing123
testing123testing123
testing123callroom
 
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTCNSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTCMauricio Lema
 
Treatment of non–small cell lung cancer
Treatment of non–small cell lung cancerTreatment of non–small cell lung cancer
Treatment of non–small cell lung cancerseayat1103
 
Innovación en terapia sistémica de cáncer de pulmón
Innovación en terapia sistémica de cáncer de pulmónInnovación en terapia sistémica de cáncer de pulmón
Innovación en terapia sistémica de cáncer de pulmónMauricio Lema
 
Neurological Complications of Venomous Snake Bites
Neurological Complications of Venomous Snake Bites Neurological Complications of Venomous Snake Bites
Neurological Complications of Venomous Snake Bites Ade Wijaya
 
Asco 2006 Update Genitourinary Cancer Selected Abstracts
Asco 2006 Update Genitourinary Cancer Selected AbstractsAsco 2006 Update Genitourinary Cancer Selected Abstracts
Asco 2006 Update Genitourinary Cancer Selected Abstractsfondas vakalis
 
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Life Sciences Network marcus evans
 
Evidence of continuous use of chloroquine (cq
Evidence of continuous use of chloroquine (cqEvidence of continuous use of chloroquine (cq
Evidence of continuous use of chloroquine (cqKwame Kumi Asare
 
Integrative regulatory genomics for target gene prioritisation in SLE
Integrative regulatory genomics for target gene prioritisation in SLEIntegrative regulatory genomics for target gene prioritisation in SLE
Integrative regulatory genomics for target gene prioritisation in SLEEnrico Ferrero
 
Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides coolesanum
 
Human Genetics For Target Discovery
Human Genetics For Target DiscoveryHuman Genetics For Target Discovery
Human Genetics For Target DiscoveryJTMulligan
 

What's hot (20)

which RA patients fits to require anti TNF alpha
which RA patients fits to require anti TNF alphawhich RA patients fits to require anti TNF alpha
which RA patients fits to require anti TNF alpha
 
Cardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial InfarctionCardiac Inflammation and Repair Following Myocardial Infarction
Cardiac Inflammation and Repair Following Myocardial Infarction
 
Copy number variations in monozygotic twins discordant for schizophrenia
Copy number variations in monozygotic twins discordant for schizophreniaCopy number variations in monozygotic twins discordant for schizophrenia
Copy number variations in monozygotic twins discordant for schizophrenia
 
Cixutumumab imc a12 ottobre 2010
Cixutumumab imc a12 ottobre 2010Cixutumumab imc a12 ottobre 2010
Cixutumumab imc a12 ottobre 2010
 
Sausville
SausvilleSausville
Sausville
 
testing123
testing123testing123
testing123
 
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTCNSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
NSCLC: diagnóstico molecular, pronóstico y seguimiento; CTC
 
Treatment of non–small cell lung cancer
Treatment of non–small cell lung cancerTreatment of non–small cell lung cancer
Treatment of non–small cell lung cancer
 
Innovación en terapia sistémica de cáncer de pulmón
Innovación en terapia sistémica de cáncer de pulmónInnovación en terapia sistémica de cáncer de pulmón
Innovación en terapia sistémica de cáncer de pulmón
 
Neurological Complications of Venomous Snake Bites
Neurological Complications of Venomous Snake Bites Neurological Complications of Venomous Snake Bites
Neurological Complications of Venomous Snake Bites
 
Asco 2006 Update Genitourinary Cancer Selected Abstracts
Asco 2006 Update Genitourinary Cancer Selected AbstractsAsco 2006 Update Genitourinary Cancer Selected Abstracts
Asco 2006 Update Genitourinary Cancer Selected Abstracts
 
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues tRNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
RNA (gene expression) analysis of Prostate cancers and non-cancerous tissues t
 
First-line Treatment In In EGFR Mutant NSCLC
First-line Treatment In In EGFR Mutant NSCLCFirst-line Treatment In In EGFR Mutant NSCLC
First-line Treatment In In EGFR Mutant NSCLC
 
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
Targeting Ras and MDS: Rigosertib Taking Aim at Important Targets-Steven Fruc...
 
Evidence of continuous use of chloroquine (cq
Evidence of continuous use of chloroquine (cqEvidence of continuous use of chloroquine (cq
Evidence of continuous use of chloroquine (cq
 
Crizo
CrizoCrizo
Crizo
 
Integrative regulatory genomics for target gene prioritisation in SLE
Integrative regulatory genomics for target gene prioritisation in SLEIntegrative regulatory genomics for target gene prioritisation in SLE
Integrative regulatory genomics for target gene prioritisation in SLE
 
Homspera march2010
Homspera march2010Homspera march2010
Homspera march2010
 
Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides Crizotinib a8081001 asco 2010 slides
Crizotinib a8081001 asco 2010 slides
 
Human Genetics For Target Discovery
Human Genetics For Target DiscoveryHuman Genetics For Target Discovery
Human Genetics For Target Discovery
 

Viewers also liked

гимназия пушкина.Jpg
гимназия пушкина.Jpg гимназия пушкина.Jpg
гимназия пушкина.Jpg mariyakorobeynikova
 
Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"
Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"
Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"Elemica
 
Dow - Household 2016
Dow - Household 2016Dow - Household 2016
Dow - Household 2016Neiri Bozzolo
 
Models of communication
Models of communicationModels of communication
Models of communicationAKHIL BHARTI
 
Візуальне відображення Інтернет-ресурсів НБ МДУ
Візуальне відображення Інтернет-ресурсів НБ МДУВізуальне відображення Інтернет-ресурсів НБ МДУ
Візуальне відображення Інтернет-ресурсів НБ МДУНБ МДУ
 
My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]
My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]
My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]Nathan C. Wood
 

Viewers also liked (12)

гимназия пушкина.Jpg
гимназия пушкина.Jpg гимназия пушкина.Jpg
гимназия пушкина.Jpg
 
Sara Im Eid
Sara Im EidSara Im Eid
Sara Im Eid
 
meu amor
meu amormeu amor
meu amor
 
cv radwan
cv radwancv radwan
cv radwan
 
Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"
Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"
Ignite 2015 NA - Noël Perry - "Transportation - A Year on the Edge"
 
Treatment of multiple sclerosis (MS)
Treatment of multiple sclerosis (MS)Treatment of multiple sclerosis (MS)
Treatment of multiple sclerosis (MS)
 
Dow - Household 2016
Dow - Household 2016Dow - Household 2016
Dow - Household 2016
 
Models of communication
Models of communicationModels of communication
Models of communication
 
CV Nadia Daraghmi
CV Nadia DaraghmiCV Nadia Daraghmi
CV Nadia Daraghmi
 
Візуальне відображення Інтернет-ресурсів НБ МДУ
Візуальне відображення Інтернет-ресурсів НБ МДУВізуальне відображення Інтернет-ресурсів НБ МДУ
Візуальне відображення Інтернет-ресурсів НБ МДУ
 
My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]
My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]
My Lean + BIM Journey [Nathan Wood, Brazil Lean Conference]
 
Good interpersonal skills
Good interpersonal skillsGood interpersonal skills
Good interpersonal skills
 

Similar to Ewrr 2007 Final (Pc)

Drug-induced Osteoporosis
Drug-induced OsteoporosisDrug-induced Osteoporosis
Drug-induced Osteoporosisdemiss
 
Sle an update_lfa_20151007
Sle an update_lfa_20151007Sle an update_lfa_20151007
Sle an update_lfa_20151007lupusdmv
 
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)Ho-Chang Kuo (郭和昌 醫師)
 
Renal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of CareRenal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of Carefondas vakalis
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...European School of Oncology
 
Clasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásicoClasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásicoMauricio Lema
 
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...MedicineAndHealthUSA
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...European School of Oncology
 
224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosis224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosisSHAPE Society
 
The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataNational Alopecia Areata Foundation
 
Khanal beltwide conference_2021
Khanal beltwide conference_2021Khanal beltwide conference_2021
Khanal beltwide conference_2021Sameer Khanal
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEFDuke Heart
 
Undergraduate Research Symposium Poster
Undergraduate Research Symposium PosterUndergraduate Research Symposium Poster
Undergraduate Research Symposium PosterTim Krueger
 
Protein-protein interaction
Protein-protein interactionProtein-protein interaction
Protein-protein interactionsigma-tau
 
Fungal infections in hematology patients: advances in prophylaxis and treatment
Fungal infections in hematology patients: advances in prophylaxis and treatmentFungal infections in hematology patients: advances in prophylaxis and treatment
Fungal infections in hematology patients: advances in prophylaxis and treatmentspa718
 

Similar to Ewrr 2007 Final (Pc) (20)

Drug-induced Osteoporosis
Drug-induced OsteoporosisDrug-induced Osteoporosis
Drug-induced Osteoporosis
 
Sle an update_lfa_20151007
Sle an update_lfa_20151007Sle an update_lfa_20151007
Sle an update_lfa_20151007
 
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
Predict of coronary artery lesions in Kawasaki disease (川崎症-郭和昌醫師)
 
Emergency Cardiology
Emergency CardiologyEmergency Cardiology
Emergency Cardiology
 
Renal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of CareRenal Cell Carcinoma A New Standard Of Care
Renal Cell Carcinoma A New Standard Of Care
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
 
Clasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásicoClasificación de riesgo en renal metastásico
Clasificación de riesgo en renal metastásico
 
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
Monoclonal Gammopathy of Undetermined Significance and Smoldering Multiple My...
 
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
Gene Profiling in Clinical Oncology - Slide 4 - L. Lacroix - New markers to d...
 
224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosis224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosis
 
224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosis224 k ras polymorphism in cancer, for atherosclerosis
224 k ras polymorphism in cancer, for atherosclerosis
 
Esv2n21
Esv2n21Esv2n21
Esv2n21
 
Device Therapy in Heart Failure
Device Therapy in Heart FailureDevice Therapy in Heart Failure
Device Therapy in Heart Failure
 
Genes + Environment
Genes + EnvironmentGenes + Environment
Genes + Environment
 
The atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areataThe atopic dermatitis pathogenesis and implications for alopecia areata
The atopic dermatitis pathogenesis and implications for alopecia areata
 
Khanal beltwide conference_2021
Khanal beltwide conference_2021Khanal beltwide conference_2021
Khanal beltwide conference_2021
 
New Treatments in HFrEF
New Treatments in HFrEFNew Treatments in HFrEF
New Treatments in HFrEF
 
Undergraduate Research Symposium Poster
Undergraduate Research Symposium PosterUndergraduate Research Symposium Poster
Undergraduate Research Symposium Poster
 
Protein-protein interaction
Protein-protein interactionProtein-protein interaction
Protein-protein interaction
 
Fungal infections in hematology patients: advances in prophylaxis and treatment
Fungal infections in hematology patients: advances in prophylaxis and treatmentFungal infections in hematology patients: advances in prophylaxis and treatment
Fungal infections in hematology patients: advances in prophylaxis and treatment
 

Ewrr 2007 Final (Pc)

  • 1. RADIOLOGICAL DAMAGE IN RHEUMATOID ARTHRTITIS IS ASSOCIATED WITH IL-6 AND IL-10 GENOTYPES INDEPENDENT OF AUTOANTIBODY PRODUCTION I Marinou, J Healy, D Mewar, D J Moore, M C Dickson, M H Binks, D S Montgomery, K Walters and A G Wilson Section of Musculoskeletal Sciences, School of Medicine & Biomedical Sciences, The University of Sheffield
  • 2.
  • 3.
  • 4.
  • 5.
  • 6. Associations of functional SNPs in IL-10 and IL-6 genes with radiographic severity of RA * Median modified Larsen scores †Cuzic’s test for trend 31 259 (30.1%) GG 0.01 † 27 415 (48.3%) AG (n=860) 24 186 (21.6%) AA IL-10-1082 32 587 (63.3%) CC 0.006 22 309 (33.3%) AC (n=928) 28 32 (3.4%) AA IL-10-592 34 282 (30.3%) GG 0.005 † 27 482 (51.8%) CG (n=930) 25 166 (17.8%) CC IL-6-174 p LS * Cases n (%) Genotype Gene D’=0.89 R 2 =0.24
  • 7. Functional SNPs in IL-10 and IL-6 are not associated with autoantibody production The presence of anti-CCP and RF was compared for each SNP with reference to the commonest genotype 78 159 57 191 GG 0.8 1.0 (0.7-1.4) 129 253 0.2 0.8 (0.5-1.1) 113 291 AG 0.6 1.1 (0.7-1.8) 52 120 0.6 1.1 (0.7-1.9) 36 138 AA IL-10-1082 169 375 138 432 CC 0.5 0.9 (0.7-1.2) 96 191 0.9 1.0 (.07-1.4) 72 222 AC 0.6 1.4 (0.6-3.7) 8 25 0.5 1.5 (06-4.5) 6 28 AA IL-10-592 77 184 64 207 GG 0.6 0.9 (0.6-1.3) 140 304 0.9 1.0 (0.7-1.4) 112 351 CG 0.1 0.7 (0.5-1.1) 56 98 0.7 0.9 (0.6-1.5) 40 120 CC IL-6-174 p OR (95%CI) RF-ve RF+ve p OR (95%CI) CCP-ve CCP+ve Genotype Gene RF status CCP status
  • 8. Associations of SNPs with RA severity are influenced by RF and CCP status Radiographic damage and genotypes stratified by CCP and RF status. Median LS is compared across genotypes according to CCP and RF status. 0.05 40 375 CC 0.002** 16 135 CC 0.002** 19 168 CC 11 103 AA/AC RF- 31 216 AA/AC RF+ 6 76 AA/AC CCP- 0.06 37 431 CC 29 250 AA/AC CCP+ IL-10 -592 p LS n Genotype Antibody status SNP
  • 9. Radiographic damage and genotypes stratified by CCP and RF status. Median LS is compared across genotypes according to CCP and RF status. 13 76 GG 0.5 17 139 GC 13 56 CC RF- 44 184 GG 0.01** 34 304 GC 30 98 CC RF+ 10 63 GG 0.9 13 109 GC 13 39 CC CCP- 41 207 GG 0.004** 32 350 GC 29 120 CC CCP+ IL-6 -174 p LS n Genotype Antibody status SNP
  • 10.
  • 11.
  • 12.

Editor's Notes

  1. The role of genetics in RA susceptibility is clearly established. However less is known of the genetic influences on disease severity. A relatively few reports have addressed the role of genetics to radiological joint damage. A relationship between DRB1 alleles and severity has been reported but recent evidence suggests that it is secondary to production of anti-CCP antibodies particularly in RF-ve patients.
  2. A central feature of RA is the imbalance of cytokine production with relative excess of proinflammatory cytokines compared to anti-inflammatory mediators. We hypothesized that genetic variants associated with cytokine production may influence disease severity and we seek for associations between functional SNPs in candidate genes and joint damage.
  3. Radiographic damage was measured using the modified Larsen score in a cross-sectional cohort of 965 RA patient all fulfilling the ARC criteria and had a minimum disease duration of 3 yrs. Radiographs of hands and feet were score blind by a single radiologist. To check consistency of the scoring 10% of the films were rescored. Taqman genotyping assays were designed for functional SNPs in IL-1, IL-6 and IL-10. Levels of RF and CCP antibodies were also measured.
  4. We fist look for associations between functional SNPs in candidate genes and radiographic severity of RA. Carriers of the IL-6 -174G allele had more severe radiographic damage compared to those having the C allele. Strong LD was detected between the 2 IL-10 SNPs as measured by D’ and r2. Patients having a copy of the IL-10 -592 C allele had increased median Larsen score compared to those having a copy of the C allele. A similar pattern, although not that significant, was observed for IL-10 -1082. Patients carrying the IL-10 -1082G allele had more severe radiographic damage compared to patients carrying the A allele.
  5. We then investigated if the presence of autoantibody-producing B-cells confound the association between genotypes and disease severity. No association between genotypes and autoantibodies was observed suggesting that the initial association with x-ray damage is not confounded by autoantibody production.
  6. The relationship between antibody status, genotypes and radiological damage was then investigated. Stratification by RF and CCP status showed that the IL-10 -592C association with LS was restricted to either RF-ve or CCP-ve patients.
  7. However the association of IL-6 -174G was only present if RF+ve or CCP+ve patients
  8. The IL-6 -174G allele was associated with more severe x-ray damage. This could be a consequence of the higher gene expression that has been previously associated with this allele. The IL-0 -592C allele was significantly associated with increase joint damage. This association could be a result of lower production levels of this anti-inflammatory cytokine. Variation in IL-10 production has been extensively associated with individual promoter SNP genotypes or haplotypes Seropositivity for both RF and CCP are associated with a more severe RA raising the possibility that our findings of IL-6/IL-10 association with median LS may be independent to the production of these severity markers. RF and CCP were not associated with either IL-6 and IL-10 genotypes suggesting that they may be independent of these severity markers. The association between IL-6 and LS was restricted to either RF+ or CCP+ patients i.e. those with more severe disease Association of IL-10 with x-ray damage was only present in RF- or CCP- patients i.e. those with milder disease
  9. Genotyping of these cytokines represent novels markers of RA severity that complement established biomarkers such as RF and CCP. These results could be useful in therapeutic targeting of expensive anti-rheumatic drugs to patients at risk of developing more severe RA